FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...
LOS ANGELES, Nov. 14, 2025 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ: CNVS), a next-generation entertainment studio, today announced its financial results for its second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback